Product information
Price | €240, €410 |
---|---|
Size | 50 µl/µg | 100 µl/µg |
Short name | RAC-beta serine, threonine-protein kinase |
Host | Mouse |
Isotype | IgG |
Target protein | AKT2 |
Recommended applications | ELISA, ICC, IF, IHC-p, WB |
Reactivity | Human, Monkey, Rat |
Immunogen | Purified recombinant fragment of human Akt2 expressed in E. Coli. |
Purification | Affinity purification |
Formulation | Ascitic fluid containing 0.03% sodium azide;0.5% BSA; 50%glycerol. |
Storage | -20°C for 1 year |
Product code | MB-AM10474 |
Additional information
Prev
Next
This gene is a putative oncogene encoding a protein belonging to a subfamily of serine/threonine kinases containing SH2-like (Src homology 2-like) domains. The gene was shown to be amplified and overexpressed in 2 of 8 ovarian carcinoma cell lines and 2 of 15 primary ovarian tumors. Overexpression contributes to the malignant phenotype of a subset of human ductal pancreatic cancers. The encoded protein is a general protein kinase capable of phophorylating several known proteins.
AKT2, RAC-beta serine, threonine-protein kinase, Protein kinase Akt-2, Protein kinase B beta, PKB beta, RAC-PK-beta
Human: P31751, Mouse: Q60823, Rat: P47197
Human: 20825233